Fig. 3: Clinical impact of hotspot versus non-hotspot mutations in recurrently mutated genes assessed using time-to-first-treatment (TTFT) as clinical endpoint.
Pairwise comparisons were performed using the Cox–Mantel log-rank test.
Fig. 3: Clinical impact of hotspot versus non-hotspot mutations in recurrently mutated genes assessed using time-to-first-treatment (TTFT) as clinical endpoint. | Leukemia
